Contribution of Immunological Memory to Protective Immunity Conferred by a Bacillus anthracis Protective Antigen-Based Vaccine
TLDR
The practical implications from the studies reported herein are that the protective capacity of memory depends on the PA dose used for the primary immunization and that the effectiveness of booster immunizations for the postexposure treatment of anthrax may be very limited when no detectable antibodies are present in primed animals prior to Bacillus anthracis spore exposure.Abstract:Â
Protective antigen (PA)-based vaccination is an effective countermeasure to anthrax infection. While neutralizing anti-PA antibody titers elicited by this vaccine serve as good correlates for protection against anthrax (S. Reuveny, M. D. White, Y. Y. Adar, Y. Kafri, Z. Altboum, Y. Gozes, D. Kobiler, A. Shafferman, and B. Velan, Infect. Immun. 69:2888-2893, 2001), no data are available on the contribution of the immunological memory for PA itself to protection. We therefore developed a guinea pig model in which a primary immunization with threshold levels of PA can induce a long-term T-cell immunological memory response without inducing detectable anti-PA antibodies. A revaccination of primed animals with the same threshold PA levels was effective for memory activation, yielding a robust and rapid secondary response. A challenge with a lethal dose (40 50% lethal doses; 2,000 spores) of spores after the booster vaccinations indicated that animals were not protected at days 2, 4, and 6 postboosting. Protection was achieved only from the 8th day postboosting, concomitant with the detection of protective levels of neutralizing antibody titers in the circulation. The practical implications from the studies reported herein are that, as expected, the protective capacity of memory depends on the PA dose used for the primary immunization and that the effectiveness of booster immunizations for the postexposure treatment of anthrax may be very limited when no detectable antibodies are present in primed animals prior to Bacillus anthracis spore exposure. Therefore, to allow for the establishment of memory-dependent protection prior to the expected onset of disease, booster immunizations should not be used without concomitant antimicrobial treatment in postexposure scenarios.read more
Citations
More filters
Journal ArticleDOI
Molecular basis for improved anthrax vaccines.
TL;DR: The next generation anthrax vaccines will be derived from the thorough understanding of the interaction of virulence factors with human and animal hosts and the role the immune response plays in providing protective immunity.
Journal ArticleDOI
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes
Ashley L. St. John,Ashley L. St. John,Cheryl Y. Chan,Herman F. Staats,Kam W. Leong,Soman N. Abraham +5 more
TL;DR: The synthetic MC adjuvants replicate and enhance the functions of MCs during vaccination, and can be extended to polarize the resulting immunity.
Journal ArticleDOI
The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant.
Orit Gat,Itai Mendelson,Theodor Chitlaru,Naomi Ariel,Zeev Altboum,Haim Levy,Shay Weiss,Haim Grosfeld,Sara Cohen,Avigdor Shafferman +9 more
TL;DR: It is proposed that MntA is a novel B.’anthracis virulence determinant essential for the development of anthrax disease, and that B. anthracisΔmntA strains have the potential to serve as platform for future live attenuated vaccines.
Journal ArticleDOI
Anthrax Lethal Toxin Has Direct and Potent Inhibitory Effects on B Cell Proliferation and Immunoglobulin Production
TL;DR: It is reported that anthrax LT directly inhibits the function of B cells in vitro and in vivo, revealing a potential mechanism through which the pathogen could bypass protective immune responses.
Journal ArticleDOI
Tropical dermatology: Bacterial tropical diseases
TL;DR: It is imperative that physicians practicing in temperate climates be able to recognize the signs and symptoms of tropical bacterial diseases, carry out the proper diagnostic tests, and initiate appropriate therapy and prevention.
References
More filters
Journal ArticleDOI
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
TL;DR: A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation and is used to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.
Journal ArticleDOI
Immunological Memory and Protective Immunity: Understanding Their Relation
Rafi Ahmed,David Gray +1 more
TL;DR: The current understanding of the cellular basis of immune memory is reviewed and the relative contributions made to protective immunity by memory and effector T and B cells are examined.
Journal ArticleDOI
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
Daniel B. Jernigan,Pratima L Raghunathan,Beth P. Bell,Ross J. Brechner,Eddy A. Bresnitz,Jay C. Butler,Marty Cetron,Mitch Cohen,Timothy J. Doyle,Marc Fischer,Carolyn M. Greene,Kevin S. Griffith,Jeannette Guarner,James L. Hadler,James A. Hayslett,Richard D. Meyer,Lyle R. Petersen,Michael R. Phillips,Robert W. Pinner,Tanja Popovic,Conrad P. Quinn,Jennita Reefhuis,Dori B. Reissman,Nancy E. Rosenstein,Anne Schuchat,Wun-Ju Shieh,Larry Siegal,David L. Swerdlow,Fred C. Tenover,Marc S. Traeger,John W. Ward,Isaac B. Weisfuse,Steven T. Wiersma,Kevin Yeskey,Sherif R. Zaki,David A. Ashford,Bradley A. Perkins,Steve Ostroff,James M. Hughes,David W. Fleming,Jeffrey P. Koplan,Julie L. Gerberding +41 more
TL;DR: A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis, and 22 cases of anthrax were identified; 5 of the inhalational cases were fatal.
Book
The comprehensive sourcebook of bacterial protein toxins
TL;DR: This work presents a meta-anatomy of the Clostridial Toxins of Serratia and Proteus Cytolsins, and some of the mechanisms behind their structure and function, as well as some examples of how these mechanisms have changed over time.
Journal ArticleDOI
Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin
TL;DR: Data imply that furin is the cellular protease that activates PA, and that nearly all cell types contain at least a small amount of furin exposed on their cell surface.